Compensatory hyperinsulinemia from insulin resistance reduces hepatic IGF binding protein production, increasing bioavailable IGF-1 that stimulates IGF-1R signaling pathways promoting cellular growth and metastatic spread (Clayton et al., 2011; Hua et al., 2020). The gene discussed is IGF1R; the disease is Hyperinsulinemia.